Published in Int J Nanomedicine on August 27, 2015
Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs. J Control Release (2016) 0.75
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 72.56
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (2001) 57.23
Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov (2008) 12.72
Gene silencing in mammals by small interfering RNAs. Nat Rev Genet (2002) 7.80
RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc Natl Acad Sci U S A (1998) 4.63
Micellar nanocontainers distribute to defined cytoplasmic organelles. Science (2003) 4.37
Ultrasound, cavitation bubbles and their interaction with cells. Adv Drug Deliv Rev (2008) 1.93
Efficient and targeted delivery of siRNA in vivo. FEBS J (2010) 1.84
Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release (2007) 1.79
Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity. Adv Drug Deliv Rev (2007) 1.66
Progress toward in vivo use of siRNAs-II. Mol Ther (2011) 1.60
Non-viral is superior to viral gene delivery. J Control Release (2007) 1.54
Efficient siRNA delivery with non-viral polymeric vehicles. Pharm Res (2008) 1.46
Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery. Biomaterials (2008) 1.28
Ultrasound-targeted microbubble destruction enhances AAV-mediated gene transfection in human RPE cells in vitro and rat retina in vivo. Gene Ther (2009) 1.21
Nanomedicine: techniques, potentials, and ethical implications. J Biomed Biotechnol (2006) 1.20
The size of sonoporation pores on the cell membrane. Ultrasound Med Biol (2009) 1.18
Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis. Small (2008) 1.11
Targeted delivery systems of small interfering RNA by systemic administration. Drug Metab Pharmacokinet (2007) 1.10
Gene therapy of carcinoma using ultrasound-targeted microbubble destruction. Ultrasound Med Biol (2011) 1.09
Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion. Crit Rev Oncol Hematol (2004) 1.09
Sonoporation, drug delivery, and gene therapy. Proc Inst Mech Eng H (2010) 1.04
Myocardial delivery of colloid nanoparticles using ultrasound-targeted microbubble destruction. Eur Heart J (2005) 0.96
Quantitative and temporal analysis of gene silencing in tumor cells induced by small interfering RNA or short hairpin RNA expressed from plasmid vectors. J Pharm Sci (2009) 0.96
A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery. Biomaterials (2012) 0.96
cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer. Biomaterials (2012) 0.90
Targeted delivery of short interfering RNAs--strategies for in vivo delivery. Recent Pat Anticancer Drug Discov (2009) 0.86
Biodistribution and renal clearance of biocompatible lung targeted poly(ethylene glycol) (PEG) nanogel aggregates. J Control Release (2012) 0.86
Introducing RGD peptides on PHBV films through PEG-containing cross-linkers to improve the biocompatibility. Biomacromolecules (2011) 0.84
siRNA delivery mediated by copolymer nanoparticles, phospholipid stabilized sulphur hexafluoride microbubbles and ultrasound. J Biomed Nanotechnol (2014) 0.82
The biocompatibility evaluation of mPEG-PLGA-PLL copolymer and different LA/GA ratio effects for biocompatibility. J Biomater Sci Polym Ed (2014) 0.79